CN Patent

CN118109468A — 诱导外显子50的跳读的反义核酸

Assigned to Nippon Shinyaku Co Ltd · Expires 2024-05-31 · 2y expired

What this patent protects

本申请涉及诱导外显子50的跳读的反义核酸。在本说明书中提供高效率地跳读人抗肌萎缩蛋白基因的第50位外显子的药剂。另外，在本说明书中提供诱导人抗肌萎缩蛋白基因的第50位外显子的跳读的反义低聚物。

USPTO Abstract

本申请涉及诱导外显子50的跳读的反义核酸。在本说明书中提供高效率地跳读人抗肌萎缩蛋白基因的第50位外显子的药剂。另外，在本说明书中提供诱导人抗肌萎缩蛋白基因的第50位外显子的跳读的反义低聚物。

Drugs covered by this patent

Patent Metadata

Patent number
CN118109468A
Jurisdiction
CN
Classification
—
Expires
2024-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.